Skip to content

Acupuncture as an Independent or Adjuvant Management to Standard Care for Perimenopausal Depression: A Systematic Review and Meta-Analysis

Zhao et al. · Frontiers in Psychiatry · 2021

📊Systematic Review and Meta-analysis👥n=2,213 women🌟High Clinical Impact

Evidence Level

MODERATE
72/ 100
Quality
3/5
Sample
4/5
Replication
4/5
🎯

OBJECTIVE

To evaluate whether acupuncture is effective for perimenopausal depression as an independent or adjuvant treatment to standard care

👥

WHO

2,213 perimenopausal women with a clinical diagnosis of depression

⏱️

DURATION

Treatments ranging from 10 days to 12 weeks, with follow-up of 2 to 24 weeks

📍

POINTS

Main points: CV-4, EX-HN3, GV-20, LI-4, LR-3, SP-6, BL-15, BL-18, BL-23, HT-7

🔬 Study Design

2213participants
randomization

Acupuncture

n=1106

Manual acupuncture or electroacupuncture

Sham Control

n=126

Sham/placebo acupuncture

Standard Care

n=981

Antidepressants and/or hormonal therapy

⏱️ Duration: 4 to 12 weeks of treatment

📊 Results in numbers

SMD = -0.54

Improvement on Hamilton Depression Scale vs. standard care

SMD = -0.82

Improvement when combined with standard care

MD = -4.55

Reduction in Kupperman Index vs. antidepressant

p < 0.01

Statistical significance

📊 Outcome Comparison

Hamilton Depression Scale (reduction)

Acupuncture
85
Standard Care
60
💬 What does this mean for you?

This study showed that acupuncture can be an effective and safe option for treating depression that affects women during the menopausal transition. Acupuncture demonstrated significant improvement in depressive symptoms, both when used alone and in combination with conventional medications. The effects were maintained for several weeks after treatment.

📝

Article summary

Plain-language narrative summary

This systematic review and meta-analysis investigated the efficacy of acupuncture in the treatment of perimenopausal depression, a condition that affects 20–40% of women during the menopausal transition. The perimenopausal period represents a window of vulnerability for the development of depression because of the dynamic hormonal fluctuations that occur in the final years of reproductive life. Many women seek therapeutic alternatives such as acupuncture because of concerns about the risks associated with antidepressants and hormone replacement therapy. The study analyzed 25 randomized clinical trials involving 2,213 women, following rigorous inclusion criteria and Cochrane methodology.

The researchers compared three main scenarios: acupuncture versus sham acupuncture, acupuncture versus standard care (antidepressants and/or hormonal therapy), and acupuncture combined with standard care versus standard care alone. Traditional Chinese acupuncture was used in all studies, including both manual technique and electroacupuncture. The results demonstrated that acupuncture was significantly superior to standard care in reducing the overall scores on the Hamilton Depression Scale, with a standardized mean difference of -0.54. When combined with standard care, acupuncture showed even more pronounced effects, with an SMD of -0.82.

The therapeutic benefits of acupuncture were maintained at follow-up of 2, 4, and 12 weeks, suggesting short-, medium-, and long-term effects. In addition to improvement in depressive symptoms, acupuncture also demonstrated superior efficacy in reducing other menopausal symptoms, as measured by the Kupperman Index. Acupuncture was well tolerated and safe, with mild and much less frequent adverse events compared with standard medications. The most common adverse events related to acupuncture were minor bruises that healed rapidly after needle removal.

By contrast, standard medications caused more significant side effects, including fatigue, palpitations, dizziness, sleep disturbances, dry mouth, and gastrointestinal symptoms. The mechanism of action of acupuncture may involve regulation of neurotransmitters such as serotonin, norepinephrine, and gamma-aminobutyric acid, although effects on sex hormone levels were not consistently different from conventional treatments. The methodological quality of the studies was rated low to moderate, mainly due to the inability to blind acupuncturists and limitations in patient blinding. Heterogeneity across studies was high, but sensitivity analyses confirmed the robustness of the main results.

Strengths

  • 1Large sample size with 2,213 participants
  • 2Long-term follow-up up to 24 weeks
  • 3Comprehensive subgroup analyses
  • 4Low incidence of adverse events
⚠️

Limitations

  • 1High heterogeneity across studies
  • 2Limited methodological quality
  • 3All studies conducted in China
  • 4Few studies with adequate sham control
Prof. Dr. Hong Jin Pai

Expert Commentary

Prof. Dr. Hong Jin Pai

PhD in Sciences, University of São Paulo

Clinical Relevance

Perimenopausal depression affects between 20% and 40% of women during the menopausal transition, and daily clinical practice confirms that a good portion of these patients reject antidepressants and hormone therapy because of concerns about adverse effects — fatigue, palpitations, dizziness, sleep changes, and gastrointestinal symptoms, all documented in this meta-analysis. With 2,213 participants in 25 randomized trials and follow-up of up to 24 weeks, this work consolidates acupuncture as a real therapeutic option, not just a complementary one. The most operationally relevant finding is the SMD of -0.82 for the combination of acupuncture plus standard care: it means that adding acupuncture to the conventional regimen produces a clinically significant additional gain. For the gynecologist or psychiatrist who has already prescribed an antidepressant or hormone and has not obtained a full response, this work offers robust support for referring the patient to the acupuncturist as an integral part of the therapeutic plan.

Notable Findings

Two findings deserve special attention. First, acupuncture outperformed standard care alone on the Hamilton scale (SMD = -0.54, p < 0.01), which by itself would be enough to justify its use; but the SMD of -0.82 in combination with standard care demonstrates therapeutic synergy — a dose-response effect of a second active intervention, not just an addition of placebo. Second, the -4.55-point reduction in the Kupperman Index versus antidepressant indicates that acupuncture acts on the constellation of vasomotor and somatic perimenopausal symptoms, not just on mood. This is clinically consistent with what we know about the action of acupuncture on the hypothalamic-pituitary axes and on the serotonergic and noradrenergic systems. The maintenance of benefits at 2-, 4-, and 12-week follow-ups suggests that the neurobiological effects persist beyond the active treatment phase.

From My Experience

In my practice, women in the 45-to-55 age range with a depressive picture associated with hot flashes, insomnia, and irritability constitute a group that responds especially well to acupuncture. I usually observe the first improvements in mood and sleep quality around the third or fourth session, with stabilization of the picture between the eighth and twelfth sessions — compatible with the 4-to-12-week protocols in this meta-analysis. When the patient is already on an antidepressant or hormonal therapy, I do not interrupt the regimen: I add acupuncture exactly as the meta-analysis suggests, and I am frequently able to reduce the antidepressant dose after 8 weeks, in agreement with the psychiatrist. The combination with relaxation techniques and counseling on sleep hygiene potentiates the results. The patient profile that responds best is the one with multiple simultaneous menopausal symptoms — mood, vasomotor, and sleep — in which acupuncture can act on all axes at once, without stacking medications.

Specialist physician in Medical Acupuncture. Adjunct Professor at the Institute of Orthopedics, HC-FMUSP. Coordinator of the Acupuncture Group at the HC-FMUSP Pain Center.

Full original article

Read the full scientific study

Frontiers in Psychiatry · 2021

DOI: 10.3389/fpsyt.2021.666988

Access original article

Scientific Review

Marcus Yu Bin Pai, MD, PhD

Marcus Yu Bin Pai, MD, PhD

CRM-SP: 158074 | RQE: 65523 · 65524 · 655241

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.

Learn more about the author →
⚕️

Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.

Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.